Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production

British Journal of Pharmacology

Volumn 139, Issue 2, 2003, Pages 329-336

  Pizurki, Lara ^a   Zhou, Zongmin ^a   Glynos, Konstantinos ^a   Roussos, Charis ^a   Papapetropoulos, Andreas ^a,b  

^a UNIVERSITY OF ATHENS   (Greece)

^b 'George P Livanos' Laboratory   (Greece)

Author keywords

Angiogenesis; Angiopoietin 1; Endothelium; IL 8; Inflammation; Neutrophils; Permeability; ROCK; Thrombin; Tie2

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANGIOPOIETIN 1; BRADYKININ; CHEMOTACTIC FACTOR; HISTAMINE; INTERLEUKIN 8; RHO KINASE; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; LUNG BLOOD VESSEL; MICROVASCULATURE; MONOLAYER CULTURE; NEUTROPHIL; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

AMIDES; ANGIOPOIETIN-1; ANIMALS; BRADYKININ; CAPILLARY PERMEABILITY; CATTLE; CELL ADHESION; CELL LINE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HISTAMINE; HUMANS; INTERLEUKIN-8; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG; NEUTROPHILS; PLATELET ACTIVATING FACTOR; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; THROMBIN;

EID: 0037592684     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705259     Document Type: Article

References (37)

1. ADAMSON, P., ETIENNE, S., COURAUD, P.O., CALDER, V. & GREENWOOD, J. (1999). Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway. J. Immunol., 162, 2964-2973.
2. BROWN, K., VORA, A., BIGGERSTAFF, J., EDGELL, C., OIKLE, S., MAZURE, G., TAUB, N., MEAGER, A., HILL, T. & WATSON, C. (1993). Application of an immortalized human endothelial cell line to the leukocyte:endothelial assay. J. Immunol. Methods, 163, 13-22.
3. DAVIS, S., ALDRICH, T.H., JONES, P.F., ACHESON, A., COMPTON, D.L., JAIN, V., RYAN, T.E., BRUNO, J., RADZIEJEWSKI, C., MAISONPIERRE, P.C. & YANCOPOULOS, G.D. (1996). Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell, 87, 1161-1169.
4. DIB, K., MELANDER, F. & ANDERSSON, T. (2001). Role of p190RhoGAP in beta 2 integrin regulation of RhoA in human neutrophils. J. Immunol., 166, 6311-6322.
5. EDGELL, C.J., MCDONALD, C.C. & GRAHAM, J.B. (1983). Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U.S.A., 80, 3734-3737.
6. ESSLER, M., AMANO, M., KRUSE, H.-J., KAIBUCHI, K., WEBER, P.C. & AEPFELBACHER, M. (1998). Thrombin inactivates myosin light chain phosphatase via rho and its target rho kinase in human endothelial cells. J. Biol. Chem., 273, 21867-21874.
7. ETO, M., BARANDIER, C., RATHGEB, L., KOZAI, T., JOCH, H., YANG, Z. & LUSCHER, T.F. (2001). Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circ. Res., 89, 583-590.
8. GAMBLE, J., DREW, J., TRESIZE, L., UNDERWOOD, A., PARSONS, M., KASMINKAS, L., RUDGE, J., YANCOPOULOS, G. & VADAS, M. (2000). Angiopoietin-1 is an anti-permeability and anti-inflammatory agent in vitro and targets cells junctions. Circ. Res., 87, 603-607.
9. HAYES, A.J., HUANG, W.Q., MALLAH, J., YANG, D., LIPPMAN, M.E. & LI, L.Y. (1999). Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc. Res., 58, 224-237.
10. HOLLAND, J.A., MEYER, J.W., CHANG, M.M., O'DONNELL, R.W., JOHNSON, D.K. & ZIEGLER, L.M. (1998). Thrombin stimulated reactive oxygen species production in cultured human endothelial cells. Endothelium, 6, 113-121.
11. JONES, N., ILJIN, K., DUMONT, D. & ALITALO, K. (2001). Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat. Rev., 2, 1-11.
12. JOUSSEN, A.M., POULAKI, V., TSUJIKAWA, A., QIN, W., QAUM, T., XU, Q., MOROMIZATO, Y., BURSELL, S.E., WIEGAND, S.J., RUDGE, J., IOFFE, E., YANCOPOULOS, G.D. & ADAMIS, A.P. (2002). Suppression of diabetic retinopathy with angiopoietin-1. Am. J. Pathol., 160, 1683-1693.
13. KAPLANSKI, G., FABRIGOULE, M., BOULAY, V., DINARELLO, C.A., BONGRAND, P., KAPLANSKI, S. & FARNARIER, C. (1997). Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-alpha-independent IL-8 secretion and E-selectin expression. J. Immunol., 158, 5435-5441.
14. KIM, I., MOON, S.O., PARK, S.K., CHAE, S.W. & KOH, G.Y. (2001). Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ. Res., 89, 477-479.
15. KIM, I., OH, J.L., RYU, Y.S., SO, J.N., SESSA, W.C., WALSH, K. & KOH, G.Y. (2002). Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells. FASEB J., 16, 126-128.
16. KOBLIZEK, T.I., WEISS, C., YANCOPOULOS, G.D., DEUTSCH, U. & RISAU, W. (1998). Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol., 8, 529-532.
17. LUM, H. & ROEBUCK, K.A. (2001). Oxidant stress and endothelial cell dysfunction. Am. J. Physiol. Cell Physiol., 280, C719-C741.
18. MAISONPIERRE, P.C., SURI, C., JONES, P.F., BARTUNKOVA, S., WIEGAND, S.J., RADZIEJEWSKI, C., COMPTON, D., MCCLAIN, J., ALDRICH, T.H., PAPADOPOULOS, N., DALY, T.J., DAVIS, S., SATO, T.N., & YANCOPOULOS, G.D. (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science, 277, 55-60.
19. NATHAN, C. (2002). Points of control in inflammation. Nature, 420, 846-852.
20. PAPAPETROPOULOS, A., FULTON, D., MAHBOUBI, K., KALB, R.G., O_CONNOR, D.S., LI, F., ALTIERI, D.C. & SESSA, W.C. (2000). Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J. Biol. Chem., 275, 9102-9105.
21. PAPAPETROPOULOS, A., GARCIA_CARDENA, G., DENGLER, T.J., MAISONPIERRE, P.C., YANCOPOULOS, G.D. & SESSA, W.C. (1999). Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab. Invest., 79, 213-223.
22. PERONA, R., MONTANER, S., SANIGER, L., SANCHEZ-PEREZ, I., BRAVO, R. & LACAL, J.C. (1997). Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev., 11, 463-475.
23. PIZURKI, L., MORRIS, M.A., CHANSON, M., SOLOMON, M., PAVIRANI, A., BOUCHARDY, I. & SUTER, S. (2000). Cystic fibrosis transmembrane conductance regulator does not affect neutrophil migration across cystic fibrosis airway epithelial monolayers. Am. J. Pathol., 156, 1407-1416.
24. RABIET, M., PLANTIER, J., RIVAL, Y., GENOUX, Y., LAMPUGNANI, M. & DEJANA, E. (1996). Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb. Vasc. Biol., 16, 488-496.
25. RAHMAN, A., ANWAR, K.N., TRUE, A.L. & MALIK, A.B. (1999). Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. J. Immunol., 162, 5466-5476.
26. SANDER, E., TEN KLOOSTER, J., VAN DELFT, S., VAN DER KAMMEN, R. & COLLARD, J. (1999). Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migration behavior. J. Cell Biol., 147, 1009-1022.
27. SATO, T.N., TOZAWA, Y., DEUTSCH, U., WOLBURG-BUCHHOLZ, K., FUJIWARA, Y., GENDRON-MAGUIRE, M., GRIDLEY, T., WOLBURG, H., RISAU, W. & QIN, Y. (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature, 376, 70-74.
28. SUGAMA, Y., TIRUPPATHI, C., OFFAKIDEVI, K., ANDERSEN, T.T., FENTON II, J.W. & MALIK, A.B. (1992). Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J. Cell Biol., 119, 935-944.
29. TAKEUCHI, S., KAWASHIMA, S., RIKITAKE, Y., UEYAMA, T., INOUE, N., HIRATA, K. & YOKOYAMA, M. (2000). Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC. Biochem. Biophys. Res. Commun., 269, 97-102.
30. THURSTON, G., RUDGE, J.S., IOFFE, E., ZHOU, H., ROSS, L., CROLL, S.D., GLAZER, N., HOLASH, J., MCDONALD, D.M. & YANCOPOULOS, G.D. (2000). Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med., 6, 460-463.
31. THURSTON, G., SURI, C., SMITH, K., MCCLAIN, J., SATO, T.N., YANCOPOULOS, G.D. & MCDONALD, D.M. (1999). Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science, 286, 2511-2514.
32. TOOTHILL, V.J., VAN MOURIK, J.A., NIEWENHUIS, H.K., METZELAAR, M.J. & PEARSON, J.D. (1990). Characterization of the enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. J. Immunol., 145, 283-291.
33. VAN NIEUW AMERONGEN, G.P., VAN DELFT, S., VERMEER, M.A., COLLARD, J.G. & VAN HINSBERGH, V.W. (2000). Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases. Circ. Res., 87, 335-340.
34. WITZENBICHLER, B., MAISONPIERRE, P.C., JONES, P., YANCOPOULOS, G.D. & ISNER, J.M. (1998). Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J. Biol. Chem., 273, 18514-18521.
35. WOJCIAK-STOTHARD, B., WILLIAMS, L. & RIDLEY, A.J. (1999). Monocyte adhesion and spreading on human endothelial cells is dependent on rho-regulated receptor clustering. J. Cell Biol., 145, 1293-1307.
36. WONG, A., HAROON, Z., WERNER, S., DEWHIRST, M., GREENBERG, C. & PETERS, K.G. (1997). Tie2 expression ad phosphorylation in angiogenic and quiescent adult tissues. Circ. Res., 81, 567-574.
37. YANCOPOULOS, G.D., DAVIS, S., GALE, N.W., RUDGE, J.S., WIEGAND, S.J. & HOLASH, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature, 407, 242-248.